SE9703693D0 - Novel combination - Google Patents

Novel combination

Info

Publication number
SE9703693D0
SE9703693D0 SE9703693A SE9703693A SE9703693D0 SE 9703693 D0 SE9703693 D0 SE 9703693D0 SE 9703693 A SE9703693 A SE 9703693A SE 9703693 A SE9703693 A SE 9703693A SE 9703693 D0 SE9703693 D0 SE 9703693D0
Authority
SE
Sweden
Prior art keywords
pct
date
novel combination
inhibitor
sec
Prior art date
Application number
SE9703693A
Other languages
English (en)
Swedish (sv)
Inventor
Peter Hamley
Alan Tinker
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Priority to SE9703693A priority Critical patent/SE9703693D0/xx
Publication of SE9703693D0 publication Critical patent/SE9703693D0/xx
Priority to EP98948031A priority patent/EP1027052A1/fr
Priority to IL13524898A priority patent/IL135248A0/xx
Priority to JP2000515595A priority patent/JP2001519391A/ja
Priority to PCT/SE1998/001792 priority patent/WO1999018960A1/fr
Priority to CA002305141A priority patent/CA2305141A1/fr
Priority to HU0003874A priority patent/HUP0003874A2/hu
Priority to EEP200000192A priority patent/EE200000192A/xx
Priority to MXPA00003445 priority patent/MXPA00003445A/es
Priority to KR1020007003824A priority patent/KR20010031017A/ko
Priority to BR9812753-5A priority patent/BR9812753A/pt
Priority to CZ20001272A priority patent/CZ20001272A3/cs
Priority to PL98339769A priority patent/PL339769A1/xx
Priority to SK428-2000A priority patent/SK4282000A3/sk
Priority to AU94693/98A priority patent/AU9469398A/en
Priority to TR2000/00928T priority patent/TR200000928T2/xx
Priority to US09/171,801 priority patent/US6046191A/en
Priority to CN98812081A priority patent/CN1281362A/zh
Priority to IS5430A priority patent/IS5430A/is
Priority to NO20001830A priority patent/NO20001830L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SE9703693A 1997-10-10 1997-10-10 Novel combination SE9703693D0 (sv)

Priority Applications (20)

Application Number Priority Date Filing Date Title
SE9703693A SE9703693D0 (sv) 1997-10-10 1997-10-10 Novel combination
CN98812081A CN1281362A (zh) 1997-10-10 1998-10-05 新的联合用药物
MXPA00003445 MXPA00003445A (es) 1997-10-10 1998-10-05 Combinacion de un inhibidor de sintetasa de oxido nitrico inducida y un inhibidor de ciclooxigenas
BR9812753-5A BR9812753A (pt) 1997-10-10 1998-10-05 Combinação farmacêutica, uso da mesma, processo para tratamento de uma doença inflamatória, e, composição farmacêutica
JP2000515595A JP2001519391A (ja) 1997-10-10 1998-10-05 新規な組み合わせ物
PCT/SE1998/001792 WO1999018960A1 (fr) 1997-10-10 1998-10-05 Nouvelle association
CA002305141A CA2305141A1 (fr) 1997-10-10 1998-10-05 Nouvelle association
HU0003874A HUP0003874A2 (hu) 1997-10-10 1998-10-05 Gyulladáscsökkentő hatású gyógyszerkombináció
EEP200000192A EE200000192A (et) 1997-10-10 1998-10-05 Uus kombinatsioon
EP98948031A EP1027052A1 (fr) 1997-10-10 1998-10-05 Nouvelle association
KR1020007003824A KR20010031017A (ko) 1997-10-10 1998-10-05 신규 제약 제제
IL13524898A IL135248A0 (en) 1997-10-10 1998-10-05 Novel combination
CZ20001272A CZ20001272A3 (cs) 1997-10-10 1998-10-05 Nová kombinace
PL98339769A PL339769A1 (en) 1997-10-10 1998-10-05 Novel combination
SK428-2000A SK4282000A3 (en) 1997-10-10 1998-10-05 Pharmaceutical combinations
AU94693/98A AU9469398A (en) 1997-10-10 1998-10-05 Novel combination
TR2000/00928T TR200000928T2 (tr) 1997-10-10 1998-10-05 Yeni kombinasyon.
US09/171,801 US6046191A (en) 1997-10-10 1998-10-05 Combination
IS5430A IS5430A (is) 1997-10-10 2000-04-06 Ný samsetning
NO20001830A NO20001830L (no) 1997-10-10 2000-04-07 Ny kombinasjon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703693A SE9703693D0 (sv) 1997-10-10 1997-10-10 Novel combination

Publications (1)

Publication Number Publication Date
SE9703693D0 true SE9703693D0 (sv) 1997-10-10

Family

ID=20408563

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9703693A SE9703693D0 (sv) 1997-10-10 1997-10-10 Novel combination

Country Status (20)

Country Link
US (1) US6046191A (fr)
EP (1) EP1027052A1 (fr)
JP (1) JP2001519391A (fr)
KR (1) KR20010031017A (fr)
CN (1) CN1281362A (fr)
AU (1) AU9469398A (fr)
BR (1) BR9812753A (fr)
CA (1) CA2305141A1 (fr)
CZ (1) CZ20001272A3 (fr)
EE (1) EE200000192A (fr)
HU (1) HUP0003874A2 (fr)
IL (1) IL135248A0 (fr)
IS (1) IS5430A (fr)
MX (1) MXPA00003445A (fr)
NO (1) NO20001830L (fr)
PL (1) PL339769A1 (fr)
SE (1) SE9703693D0 (fr)
SK (1) SK4282000A3 (fr)
TR (1) TR200000928T2 (fr)
WO (1) WO1999018960A1 (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701304D0 (sv) * 1997-04-09 1997-04-09 Astra Pharma Prod Compounds
TR200401803T2 (tr) * 1998-08-11 2004-11-22 Pfizer Products Inc. NOS önleyicileri için yeni farmasötik kullanımlar.
KR100793668B1 (ko) 1999-12-08 2008-01-10 파마시아 코포레이션 강화된 생체이용률을 지닌 고체상 형태의 셀레콕시브
AP2002002582A0 (en) * 1999-12-23 2002-09-30 Nitromed Inc Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
GB0004153D0 (en) * 2000-02-23 2000-04-12 Astrazeneca Uk Ltd Novel use
US6589557B2 (en) * 2000-06-15 2003-07-08 Acusphere, Inc. Porous celecoxib matrices and methods of manufacture thereof
US6800297B2 (en) * 2000-06-15 2004-10-05 Acusphere, Inc. Porous COX-2 inhibitor matrices and methods of manufacture thereof
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
AU2001285334A1 (en) * 2000-08-29 2002-03-13 Peter Van Patten Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid
IN191090B (fr) * 2000-08-29 2003-09-20 Ranbanx Lab Ltd
US7012098B2 (en) * 2001-03-23 2006-03-14 Pharmacia Corporation Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
US20030035795A1 (en) * 2001-04-13 2003-02-20 Gardell Stephen J. Methods for treating or reducing the risk of pain and inflammatory disorders by administering inhibitors of activated thrombin activatable fibrinolysis inhibitor
US20020187187A1 (en) * 2001-04-21 2002-12-12 Toshimitsu Ohki Fast disintegrating meloxicam tablet
AR035700A1 (es) * 2001-05-08 2004-06-23 Astrazeneca Ab Derivados de arilheteroalquilamina, composicion farmaceutica, usos de estos derivados para la fabricacion de medicamentos, metodos de tratamiento, y proceso para la preparacion de estos derivados
US20030114418A1 (en) * 2001-08-14 2003-06-19 Pharmacia Corporation Method for the treatment and prevention of pain and inflammation with glucosamine and a cyclooxygenase-2 selective inhibitor and compositions therefor
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
EP1448209A2 (fr) * 2001-10-23 2004-08-25 Ranbaxy Laboratories, Ltd. Procede de preparation de compositions pharmaceutiques servant a administrer localement des inhibiteurs de l'enzyme cyclooxygenase-2
WO2003041705A1 (fr) * 2001-11-13 2003-05-22 Pharmacia Corporation Forme posologique orale d'un promedicament au sulfonamide, tel que le parecoxib
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
KR20050005410A (ko) * 2002-02-19 2005-01-13 파마시아 코포레이션 요실금 치료용으로서의 시클로옥시게나제 저해제 및항무스카린제의 용도
CA2487414A1 (fr) 2002-06-11 2003-12-18 Nitromed, Inc. Inhibiteurs selectifs de cyclooxigenase-2 nitroses et/ou nitrosyles, compositions et methodes d'utilisation
US7244753B2 (en) * 2002-07-29 2007-07-17 Nitromed, Inc. Cyclooxygenase-2 selective inhibitors, compositions and methods of use
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1622630B1 (fr) * 2003-05-07 2012-08-29 Osteologix A/S Composition contenant entre autres du strontium pour la prophylaxie et/ou le traitement de pathologies des cartilages et/ou des os
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
EP1568369A1 (fr) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Utilisation du meloxicam pour le traitement de maladies respiratoires des porcs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
CA2570503A1 (fr) * 2004-06-17 2005-12-29 Osteologix A/S Procede ameliorant le traitement medical de la douleur
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
CA2623201A1 (fr) * 2005-09-30 2007-04-12 Boehringer Ingelheim Vetmedica Gmbh Preparation pharmaceutique qui contient du meloxicam
CA2628074C (fr) 2005-10-25 2014-01-14 Shionogi & Co., Ltd. Derive aminodihydrothiazine
JP2007275193A (ja) * 2006-04-04 2007-10-25 Fujifilm Corp 光プローブおよび光断層画像化装置
GB0712287D0 (en) * 2007-06-22 2007-08-01 Ucl Business Plc Antimicrobial Conjugates
US20090317436A1 (en) * 2006-08-04 2009-12-24 Mike Wilson Computer devices and accessories
EP2114461A2 (fr) * 2007-01-19 2009-11-11 Mallinckrodt Inc. Ligands de liaison à la cycloxygénase-2 diagnostiques et thérapeutiques
JP5383484B2 (ja) 2007-04-24 2014-01-08 塩野義製薬株式会社 環式基で置換されたアミノジヒドロチアジン誘導体
US8653067B2 (en) 2007-04-24 2014-02-18 Shionogi & Co., Ltd. Pharmaceutical composition for treating Alzheimer's disease
DE102007049612A1 (de) * 2007-10-17 2009-06-10 Evonik Goldschmidt Gmbh Bioaktive Zusammensetzung für kosmetische Anwendungen
KR101324426B1 (ko) 2008-06-13 2013-10-31 시오노기세야쿠 가부시키가이샤 β 세크레타제 저해 작용을 갖는 황 함유 복소환 유도체
CN102186841A (zh) 2008-10-22 2011-09-14 盐野义制药株式会社 具有bace1抑制活性的2-氨基嘧啶-4-酮及2-氨基吡啶衍生物
ES3037313T3 (en) * 2009-10-12 2025-09-30 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
MX2012006491A (es) 2009-12-11 2012-07-03 Shionogi & Co Derivados de oxazina.
MX2012010077A (es) 2010-03-03 2012-09-12 Boehringer Ingelheim Vetmed Uso de meloxicam para el tratamiento a largo plazo de trastornos musculoesqueleticos en gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
EP2634188A4 (fr) 2010-10-29 2014-05-07 Shionogi & Co Dérivé d'aminodihydropyrimidine fusionnée
JP5816630B2 (ja) 2010-10-29 2015-11-18 塩野義製薬株式会社 ナフチリジン誘導体
US8883779B2 (en) 2011-04-26 2014-11-11 Shinogi & Co., Ltd. Oxazine derivatives and a pharmaceutical composition for inhibiting BACE1 containing them
EP2912035A4 (fr) 2012-10-24 2016-06-15 Shionogi & Co Dérivés de dihydrooxazine ou d'oxazépine ayant une activité inhibitrice de bace1

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0833664A1 (fr) * 1995-06-12 1998-04-08 G.D. SEARLE & CO. Traitement d'inflammations par une combinaison d'un inhibiteur de la cyclooxygenase-2 et d'un antagoniste du recepteur de leukotriene b 4?
ES2247604T3 (es) * 1995-06-12 2006-03-01 G.D. SEARLE & CO. Composiciones que comprenden un inhibidor de ciclooxigenasa-2 y un inhibidor de 5-lipoxigenasa.
DK0880363T3 (da) * 1996-02-13 2003-01-20 Searle & Co Kombinationer der omfatter en cyclooxygenase-2 hæmmer samt en leukotrien A4 hydrolasehæmmer, som har immunsuppressive virkninger

Also Published As

Publication number Publication date
SK4282000A3 (en) 2001-01-18
KR20010031017A (ko) 2001-04-16
US6046191A (en) 2000-04-04
BR9812753A (pt) 2000-08-29
EE200000192A (et) 2001-04-16
CN1281362A (zh) 2001-01-24
NO20001830D0 (no) 2000-04-07
MXPA00003445A (es) 2001-06-01
PL339769A1 (en) 2001-01-02
AU9469398A (en) 1999-05-03
JP2001519391A (ja) 2001-10-23
CZ20001272A3 (cs) 2000-09-13
IS5430A (is) 2000-04-06
EP1027052A1 (fr) 2000-08-16
WO1999018960A1 (fr) 1999-04-22
NO20001830L (no) 2000-05-10
TR200000928T2 (tr) 2000-11-21
IL135248A0 (en) 2001-05-20
CA2305141A1 (fr) 1999-04-22
HUP0003874A2 (hu) 2001-05-28

Similar Documents

Publication Publication Date Title
SE9703693D0 (sv) Novel combination
SE9802333D0 (sv) Novel combination
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
TR200102499T2 (tr) Neoplazi tedavisinde bir kombinasyon terapisi olarak bir siklooksijenaz-2 inhibitörü ve bir veya daha fazla antineoplastik ajan kullanma yöntemi
YU53899A (sh) Primena inhibitora ciklooksigenaze-2 u prevenciji kardiovaskularnih poremećaja
MXPA04003668A (es) Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
TR199801930T2 (xx) 6-Fenilpiridil-2-amin t�revleri.
NO20014303D0 (no) JAK-3-inhibitorer for behandling av allergiske lidelser
EE200300559A (et) Osteopontiini kasutamine neuroloogiliste haigusteraviks ja/või vältimiseks
MXPA05009986A (es) Tratamiento de la enfermedad de alzheimer.
PT1032414E (pt) Combinacao de um inibidor da enzima de conversao da angiotensina e de um diuretico para o tratamento de perturbacoes microcirculatorias
EA200000165A1 (ru) Разветвленные алкоксизамещенные-2-аминопиридины в качестве ингибиторов nos
ATE249835T1 (de) Immunoregulator
HRP20031057B1 (hr) Tableta koja sadrži cetirizin i pseudoefedrin
CY1107039T1 (el) Αναστολεις τριπεπτιδυλ πεπτιδασης
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
PT1071463E (pt) Metodos e composicoes utilizando metabolitos de terfenadina em combinacao com inibidores de leucotrieno
HRP20050579B1 (hr) Nove sinergistiäśne kombinacije koje sadrže roflumilast i formoterol
IL139144A0 (en) Mycobacterial inhibitors
NO20045343L (no) Ny kombinasjon for behandling av luftveisforstyrrelser
DK0774961T3 (da) Anvendelse af selegilin til behandling af epileptiske lidelser
ID20794A (id) Penggunaan inhibitor penukar natrium-hidrogen untuk pembuatan sediaan farmasi untuk pengobatan gangguan yang disebabkan oleh protozoa
HRP20050580A2 (en) Synergistic combination comprising roflumilast and (r,r)-formoterol
BR0314364A (pt) Uso de inibidores de pde iv para tratar angiogênese
DK1144348T3 (da) LTA4-hydrolaseinhibitorer